Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Rosetta Genomics, Ltd. (ROSG)

-NasdaqCM

3.40 Down 0.15(4.23%) May 17, 3:59PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 201   103   279  
Cost of Revenue258  324  628  
Gross Profit (57) (221) (349)
Operating Expenses
Research Development1,247  3,386  5,707  
Selling General and Administrative6,963  5,170  7,859  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (8,267) (8,777) (13,915)
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -  
Earnings Before Interest And Taxes(10,696)(7,393)(12,973)
Interest Expense -   -   -  
Income Before Tax(10,696)(7,393)(12,973)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(10,696)(7,393)(12,973)
Non-recurring Events
Discontinued Operations239  (1,437)(1,782)
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (10,457) (8,830) (14,755)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (10,457) (8,830) (14,755)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.